SCHEMBL741425

SCHEMBL741425

COCCCn1c(C2CCCN(C(=O)CC(N)Cc3ccc(-c4cnc(N)nc4)cc3)C2)nc2c(F)cccc21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CFD P00746 2/20 0.36
BTK Q06187 2/20 0.36
HRH1 P35367 4/20 0.34
CYP2D6 P10635 3/20 0.34
MAPK1 P28482 2/20 0.33
DPP4 P27487 5/20 0.33
KCNH2 Q12809 2/20 0.33
MAP3K12 Q12852 1/20 0.33
FEN1 P39748 1/20 0.33
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
JAK3 P52333 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
GRIN2B Q13224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741424 1.00 CFD (0.36) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL741441 0.94 CFD (0.36) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL741440 0.94 CFD (0.36) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL742008 0.93 CFD (0.35) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL742009 0.93 CFD (0.35) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL740772 0.91 HTT (0.39) CFDBTKHRH1CYP2D6DPP4
SCHEMBL740771 0.91 HTT (0.39) CFDBTKHRH1CYP2D6DPP4
SCHEMBL740825 0.90 CFD (0.36) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL740824 0.90 CFD (0.36) CFDBTKHRH1CYP2D6MAPK1
SCHEMBL741913 0.89 KCNH2 (0.43) BTKHRH1CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed